There is 1 paper on non-AIDS-defining cancer risk in aging research: 1 observational study in people.
1 paper studies it1 more mentions it1 finding
See all 2 papers on non-AIDS-defining cancer risk
“Increased 4-HNE levels were associated with higher NADC risk in females (aHR = 2.79 [95% CI, 1.14-6.80]) but not in males”
- Humans1
Associations
14-hydroxynonenal
upin humans1
1 study
4-hydroxynonenal
upin humans1
4-hydroxynonenal is associated with non-AIDS-defining cancer risk in humans (People with HIV receiving antiretroviral therapy; exploratory subgroup analysis) (aHR 2.79, 95% CI 1.14–6.80).
“Increased 4-HNE levels were associated with higher NADC risk in females (aHR = 2.79 [95% CI, 1.14-6.80]) but not in males”
HumansPeople with HIV receiving antiretroviral therapy; exploratory subgroup analysisplasmafemales
GeroScience
Latest
1 paper in 12 monthsFrontiers in Immunology
Immune and senescence profiles associated with non-AIDS-defining cancer risk in people with HIV: a case-cohort study
Cohort study of 316 peopleBiomarkers